Explore a little further

Collaboration

Stories and perspectives from Daytrade News.

From Daytrade News

12 stories shown · Newest added
Daytrade News

CRISPR Therapeutics Faces Stock Challenges Despite Analyst Optimism

CRISPR Therapeutics has seen its stock price decline over the past year, trading significantly below Wall Street's price targets. Analysts predict potential gains, with one projecting an 86% upside based on the company's gene therapy product, CASGEVY, which has shown strong reve…

Daytrade News

Nike 78% drop: GO WOKE, GO BROKE

Nike has experienced a dramatic decline in its stock value, losing approximately 78% since its peak in 2021. This downturn has led to the company's removal from the S&P 100 index,…

More perspectives

Across our publications

A selection of related stories